TNFSF10 and neoplasm: However, given the complexity of the TRAIL system, further studies in primary tumor cells of diverse origin along with validation studies through syngenic and xenograft mice models and clinical trials would be required to develop personalized medicine on the basis of the TRAIL/TRAIL receptor pathway.